GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

AIM Vaccine Co 6660.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

1.52

-2.56%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥1.36bn

FY2019FY2025

Net income

−CN¥786.5m

FY2019FY2025

Free cash flow

−CN¥199.6m

FY2019FY2025

Shareholders' equity

CN¥3.21bn

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
RevenueCN¥1.36bnCN¥1.29bnCN¥1.19bnCN¥1.26bnCN¥1.57bnCN¥1.64bnCN¥1.11bn
Gross profitCN¥885.2mCN¥953.5m−CN¥611.2mCN¥1.03bnCN¥1.29bnCN¥1.35bnCN¥867.6m
Research and developmentCN¥222.7mCN¥363.1mCN¥2.15bnCN¥500.3mCN¥307.4mCN¥157.8mCN¥115.1m
Operating income−CN¥242.1m−CN¥237.4m−CN¥3.51bn−CN¥419.2m−CN¥648.7mCN¥501.6mCN¥187.6m
Net income−CN¥786.5m−CN¥277.2m−CN¥1.30bn−CN¥319.6m−CN¥692.8mCN¥379.3mCN¥136.7m
Diluted earnings per share-0.64-0.23-1.07-0.27-0.720.440.16

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assetsCN¥7.62bnCN¥8.52bnCN¥8.46bnCN¥10.34bnCN¥9.40bnCN¥4.69bn—
Cash and short-term investmentsCN¥448.0mCN¥692.7mCN¥857.5mCN¥953.6mCN¥869.6mCN¥1.10bnCN¥58.2m
Total liabilitiesCN¥4.03bnCN¥4.31bnCN¥3.93bnCN¥3.51bnCN¥2.76bnCN¥1.27bn—
DebtCN¥2.05bnCN¥1.84bnCN¥1.80bnCN¥1.40bnCN¥650.4mCN¥235.0mCN¥314.4m
Shareholders' equityCN¥3.21bnCN¥3.92bnCN¥4.24bnCN¥5.78bnCN¥5.70bnCN¥3.42bn—
Shares outstanding1,227m1,211m1,211m1,205m962m862m834m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operationsCN¥78.6mCN¥99.2m−CN¥165.5m−CN¥128.5mCN¥108.8mCN¥250.3mCN¥380.8m
Capital spending−CN¥278.2m−CN¥238.3m−CN¥301.6m−CN¥997.5m−CN¥1.33bn−CN¥667.0m−CN¥403.1m
Free cash flow−CN¥199.6m−CN¥139.1m−CN¥467.1m−CN¥1.13bn−CN¥1.22bn−CN¥416.7m−CN¥22.3m
Dividends paid——————−CN¥100.1m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueCN¥402.7mCN¥758.1mCN¥599.3mCN¥747.9mCN¥537.2mCN¥647.0mCN¥540.5mCN¥672.5m
Gross profitCN¥267.0mCN¥487.9mCN¥397.4mCN¥565.2mCN¥388.3m−CN¥1.04bnCN¥432.6mCN¥546.0m
Operating income−CN¥132.2m−CN¥82.5m−CN¥153.3m−CN¥86.7m−CN¥124.2m−CN¥3.20bn−CN¥310.1m−CN¥306.2m
Net income−CN¥141.0m−CN¥633.9m−CN¥152.7m−CN¥138.0m−CN¥139.3m−CN¥1.05bn−CN¥250.4m−CN¥274.7m
Diluted earnings per share-0.11-0.52-0.12-0.11-0.11-0.87-0.21-0.23
Cash from operations−CN¥56.0mCN¥191.0m−CN¥112.0mCN¥196.0m−CN¥97.0mCN¥97.0m−CN¥249.0m−CN¥34.0m
Capital spending−CN¥29.0m−CN¥216.0m−CN¥61.0m−CN¥71.0m−CN¥50.0m−CN¥90.0m−CN¥80.0m−CN¥343.0m
Free cash flow−CN¥85.0m−CN¥25.0m−CN¥173.0mCN¥125.0m−CN¥147.0mCN¥7.0m−CN¥329.0m−CN¥377.0m
Total assetsCN¥7.38bnCN¥7.62bnCN¥8.37bnCN¥7.31bnCN¥7.32bnCN¥7.26bnCN¥8.88bnCN¥10.34bn
Cash and short-term investmentsCN¥224.9mCN¥448.0mCN¥467.9mCN¥594.9mCN¥655.3mCN¥736.4mCN¥754.9mCN¥929.0m
DebtCN¥1.70bnCN¥2.05bnCN¥2.07bnCN¥1.84bnCN¥1.96bnCN¥1.80bnCN¥1.69bnCN¥1.59bn
Shareholders' equityCN¥3.07bnCN¥3.21bnCN¥3.85bnCN¥3.37bnCN¥3.50bnCN¥3.64bnCN¥4.69bnCN¥5.78bn

Financial ratios

Data as of 24 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin65.9%74.2%-51.5%81.3%82.5%82.7%
Operating margin-18.0%-17.9%-187.5%-32.3%-38.0%30.6%
Net margin-58.5%-21.6%-109.6%-25.3%-44.1%23.2%
Return on equity-24.5%-8.2%-35.7%-6.4%-14.2%11.1%
Return on assets-10.3%-3.8%-17.9%-3.6%-8.6%8.1%
Free cash flow yield3.7%5.4%-9.1%-6.1%——
Revenue growth-10.2%8.2%-6.1%-19.5%-4.1%72.1%
Earnings growth143.6%-78.7%307.1%-53.9%-282.7%223.1%
Current ratio0.66x0.77x0.95x1.13x1.50x2.16x
Debt to equity0.64x0.54x0.49x0.28x0.12x0.06x
Equity ratio42.2%46.0%50.2%55.9%60.6%73.0%
Interest coverage-3.69x-3.78x-50.80x-15.90x-55.69x31.87x
R&D as a share of sales16.6%28.3%180.9%39.6%19.6%9.6%
Buybacks as a share of market value-1.3%0.0%-0.5%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.4%-3.7%—
Operating income-16.7%——
Net income35.0%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin69.6%44.3%59.1%—
Operating margin-18.1%-86.6%-54.9%—
Net margin-40.3%-52.7%-36.1%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings-4.3-23.2-6.3-38.0
Price to sales2.55.06.99.6

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.